4 min read
Metabolic Comorbidity in Preclinical Stroke, Pain and Wound Models
Among US adults aged 60 and older, metabolic syndrome prevalence reached roughly 62 percent by 2021 to 2023 in a...
Nov 17, 2026by MD Biosciences
Among US adults aged 60 and older, metabolic syndrome prevalence reached roughly 62 percent by 2021 to 2023 in a...
Nov 10, 2026by MD Biosciences
The pain and neurology pipeline comprises several distinct therapeutic modalities. A neuropathic pain program today may...
Nov 3, 2026by MD Biosciences
Remyelination trials in multiple sclerosis are judged on imaging and functional endpoints because myelin cannot be...
Oct 27, 2026by MD Biosciences
Pain is a principal presenting symptom of rheumatoid arthritis, and persistent pain despite low inflammatory activity...
Oct 20, 2026by MD Biosciences
The clinical value of a non-opioid analgesic is defined relative to the established agents it is intended to replace,...